Medicus Pharma (MDCX) Enterprise Value (2023 - 2025)

Medicus Pharma has reported Enterprise Value for 3 years, with the latest figure at -$8.6 million in Q4 2025.

• For the quarter ending Q4 2025, Enterprise Value fell 106.52% year-over-year to -$8.6 million; the trailing twelve-month figure through Dec 2025 stood at -$8.6 million (down 106.52% YoY), and the FY2025 full-year result was -$8.6 million, down 106.52% from the prior year.
• Enterprise Value for Q4 2025 stood at -$8.6 million, down from -$8.6 million in the prior quarter.
• The five-year high for Enterprise Value was -$1.7 million in Q4 2023, with the low at -$9.7 million in Q2 2025.
• Historically, Enterprise Value has averaged -$6.1 million across 3 years, with a median of -$6.4 million in 2024.
• Annual changes were most pronounced in 2024 — Enterprise Value sank 142.21% — and 2025, when it plunged 106.52%.
• Medicus Pharma's Enterprise Value stood at -$1.7 million in 2023, then tumbled by 142.21% to -$4.2 million in 2024, then sank by 106.52% to -$8.6 million in 2025.
• The last three Enterprise Value figures came in at -$8.6 million (Q4 2025), -$8.6 million (Q3 2025), and -$9.7 million (Q2 2025), per Business Quant data.